Perfil
K.
Chris Min worked as a Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and as VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min completed his undergraduate degree at Harvard University and earned his doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Antiguos cargos conocidos de K. Min.
| Empresas | Cargo | Fin |
|---|---|---|
| LONGEVERON INC. | Chief Executive Officer | 01/03/2023 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Formación de K. Min.
| Harvard University | Undergraduate Degree |
| The Rockefeller University | Doctorate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
| Bluerock Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- K. Min
